ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Tenon Medical's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was -173.57%.
As of today (2026-07-05), Tenon Medical's WACC % is 11.70%. Tenon Medical's ROC % is -254.85% (calculated using TTM income statement data).
Tenon Medical earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Tenon Medical (NAS:TNON) ROC % Explanation
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Tenon Medical's WACC % is 11.70%. Tenon Medical's ROC % is -254.85% (calculated using TTM income statement data).
Tenon Medical earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Tenon Medical ROC % Related Terms
Tenon Medical ROC % Historical Data
* Premium members only.
The historical data trend for Tenon Medical's ROC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Operating Income data used here is four times the quarterly (Mar. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenon Medical (TNON) has a ROC % of -173.57% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Tenon Medical and its competitors.
Is Tenon Medical's ROC % too high?
Tenon Medical's current ROC % is -173.57%. Overall, Tenon Medical has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tenon Medical's ROC % compare to XAIR and VVOS?
Tenon Medical's ROC % of -173.57% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROC % is 1.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Devices & Instruments company?
The median ROC % among Medical Devices & Instruments companies is 1.26, based on 846 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Tenon Medical and its competitors. For the Medical Devices & Instruments industry, the median ROC % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenon Medical's current ROC % is -173.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenon Medical stock overvalued right now?
Based on GuruFocus' analysis, Tenon Medical (TNON) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.29 — trading 18% below its estimated fair value. The current ROC % is -173.57%. Tenon Medical's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Tenon Medical (TNON), the current ROC % is -173.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tenon Medical (TNON) Overvalued in 2026?
Based on GuruFocus' analysis, Tenon Medical stock appears to be undervalued.
The current stock price of $0.29 is trading 18% below its estimated GF Value™ of $0.35.
GuruFocus considers Tenon Medical to be Modestly Undervalued.
Key valuation signals for TNON:
ROC %: -173.57%
GF Value™: $0.35 vs. price of $0.29 (18% below fair value)
No single metric tells the full story. See the TNON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
38GF Score
Get the complete analysis for TNON
ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TNON has been successfully added to your 
